Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.

 

The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.

 

The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


AIVL: This AI-Powered ETF Still Has To Prove Itself

2025-01-16
WisdomTree U.S. AI Enhanced Value Fund (AIVL) is a new ETF targeting value stocks with AI model, but lags S&P Mid-Cap 400 Index. Read a review here.

Boston Scientific Standing Apart As A Rare Med-Tech Growth Story

2025-01-14
Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn more about BSX stock here.

Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

2025-01-13
Medtronic plc (NYSE:MDT) 43rd Annual J.P. Morgan Healthcare Conference Call January 13, 2025 5:15 PM ETCompany ParticipantsGeoff Martha - Chief Executive...

Medtronic's Hypertension Device to Be Reviewed by Medicare

2025-01-13
By Sabela Ojea Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its...

Medtronic : expands U.S. carotid market presence with exclusive Contego Medical distribution agreement

2025-01-13
Medtronic, the global leader in healthcare technology, today announced it has entered into an exclusive U.S. distribution agreement with Raleigh, North Carolina-based Contego Medical. Under the...

Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology

2025-01-13
European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's diseaseGALWAY, Ireland, Jan. 13, 2025 /PRNewswire/ --...

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

2025-01-09
J&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips.

Medtronic inks exclusive deal to sell Kuros bone graft device

2025-01-09
In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.

5 medtech trends to watch in 2025

2025-01-09
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

2025-01-08
Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.